These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32398249)

  • 61. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).
    Ahmadieh H; Vafi N
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1731-3. PubMed ID: 17653753
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
    Cho HJ; Kim K; Lim SH; Kang DH; Kim JW
    Br J Ophthalmol; 2020 Oct; 104(10):1443-1447. PubMed ID: 31896542
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up.
    Inan S; Baysal Z; Inan UU
    Curr Eye Res; 2019 Aug; 44(8):908-915. PubMed ID: 30909756
    [No Abstract]   [Full Text] [Related]  

  • 65. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
    Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P
    Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
    Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-VEGF therapy in a silicone oil-filled myopic eye with choroidal neovascularisation.
    Chhablani J; Narayanan R
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25870215
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Subretinal injection of ranibizumab in advanced pediatric vasoproliferative disorders with total retinal detachments.
    Peng J; Liang T; Chen C; Zhang Q; Xu Y; Liu J; Zhao P
    Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1005-1012. PubMed ID: 32043167
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation.
    Xiao H; Zhao X; Li S; Sun L; Xin W; Wang Z; Zhang A; Zhang J; Ding X
    Br J Ophthalmol; 2021 Jan; 105(1):103-108. PubMed ID: 32161005
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Spatial Correspondence Between Intraretinal Fluid, Subretinal Fluid, and Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration.
    Klimscha S; Waldstein SM; Schlegl T; Bogunovic H; Sadeghipour A; Philip AM; Podkowinski D; Pablik E; Zhang L; Abramoff MD; Sonka M; Gerendas BS; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4039-4048. PubMed ID: 28813577
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
    Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structural and optical coherence tomography angiography in myopic choroidal neovascularization: Agreement with conventional fluorescein angiography.
    Iacono P; Giorno P; Varano M; Parravano M
    Eur J Ophthalmol; 2021 Jan; 31(1):149-157. PubMed ID: 31619075
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.
    Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Choroidal nevus or melanoma? Choroidal neovascularisation as a confounder in choroidal nevus.
    Subira O; Brosa H; Lorenzo D; Caminal JM
    J Fr Ophtalmol; 2017 Jun; 40(6):531-534. PubMed ID: 28579218
    [No Abstract]   [Full Text] [Related]  

  • 76. Treatment of serous retinal detachment associated with choroidal ischemia with intravitreal bevacizumab following brain surgery.
    Cho YJ; Choi EY; Koh HJ; Lee SC; Kim M
    Korean J Ophthalmol; 2014 Oct; 28(5):424-6. PubMed ID: 25276086
    [No Abstract]   [Full Text] [Related]  

  • 77. Prediction of Anti-VEGF Treatment Requirements in Neovascular AMD Using a Machine Learning Approach.
    Bogunovic H; Waldstein SM; Schlegl T; Langs G; Sadeghipour A; Liu X; Gerendas BS; Osborne A; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3240-3248. PubMed ID: 28660277
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.
    Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C
    Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.
    Punjabi OS; Huang J; Rodriguez L; Lyon AT; Jampol LM; Mirza RG
    Br J Ophthalmol; 2013 Aug; 97(8):1024-31. PubMed ID: 23759437
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab.
    Patel KH; Chow CC; Rathod R; Mieler WF; Lim JI; Ulanski LJ; Leiderman YI; Arun V; Chau FY
    Eye (Lond); 2013 May; 27(5):663-7; quiz 668. PubMed ID: 23558214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.